A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients With a History of Myocardial Infarction and Additional Risk Factors for Atherothrombosis
HELICON
1 other identifier
observational
100,000
1 country
1
Brief Summary
To characterize and estimate the size of different populations with a history of acute coronary syndrome in Sweden. To assess the burden of illness (co-morbidities, mortality rates healthcare resource utilization and atherothrombotic events) among patients with a history of myocardial infarction (MI) 1-3 years ago and additional risk factors for atherothrombosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 22, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedFirst Posted
Study publicly available on registry
November 14, 2013
CompletedMay 13, 2014
May 1, 2014
3 months
October 22, 2013
May 12, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Description of study population in terms of death, cardiovascular disease events and health care resource utilization
1\. Death (all cause and CVD death) 2. CVD event (MI or Stroke) 3. Health care resource use and costs.
Follow up period 1-7 years
Assessment of the burden of illness among high risk patients with a history of MI
1\. Describe patients' demographics and clinical characteristics 2. Assess rate of CV event (MI and stroke), CV mortality and all cause mortality 3. Assess rate of CV events (MI and stroke), CV mortality and all cause mortality in patients having at least 24 months and 36 months without MI, respectively 4. Assess the impact of additional atherothrombotic risk factors 5. Describe treatment patterns 6. Evaluate healthcare resource use and costs 7. Assess predictors of new CV events (MI and stroke), CV mortality and all cause mortality
Follow up period 1-7 years
Assessment of the mortality rates among high risk patients with a history of MI
1\. Describe patients' demographics and clinical characteristics 2. Assess rate of CV event (MI and stroke), CV mortality and all cause mortality 3. Assess rate of CV events (MI and stroke), CV mortality and all cause mortality in patients having at least 24 months and 36 months without MI, respectively 4. Assess the impact of additional atherothrombotic risk factors 5. Describe treatment patterns 6. Evaluate healthcare resource use and costs 7. Assess predictors of new CV events (MI and stroke), CV mortality and all cause mortality
Follow up period 1-7 years
Secondary Outcomes (1)
Description of the high risk patient population in terms of CVD events, bleedings and co-morbidities.
Follow up period 1-7 years
Eligibility Criteria
Patient with acute coronary syndrome with a history of MI 1-3 years ago.
You may qualify if:
- \- Patients hospitalised for ACS between 01.07.2006 and 31.06.2011.
You may not qualify if:
- \- Not applicable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (1)
Research Site
Linköping, Sweden
Related Publications (1)
Janzon M, Henriksson M, Hasvold P, Hjelm H, Thuresson M, Jernberg T. Long-term resource use patterns and healthcare costs after myocardial infarction in a clinical practice setting: results from a contemporary nationwide registry study. Eur Heart J Qual Care Clin Outcomes. 2016 Oct 1;2(4):291-298. doi: 10.1093/ehjqcco/qcw019.
PMID: 29474723DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Magnus Janzon, MD, PhD
Department of Cardiology, Linköping University Hospital, S-581 85 Linköping, Sweden
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2013
First Posted
November 14, 2013
Study Start
August 1, 2013
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
May 13, 2014
Record last verified: 2014-05